Doctor profile · Federal record

Dr. Jonathan Amos, M.D.

Rheumatology Physician (CMS: Rheumatology) · Student in an Organized Health Care Education/Training Program · Overland Park, KS

  • NPI 1740660604
  • Accepts Medicare
  • MIPS 97.9 / 100 · 2023
  • 11 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
5701 W 119Th St Ste 209
Overland Park, KS 662093749
(913) 661-9980
fax (913) 661-9173

Credentials & registration

NPPES · NUCC
NPI registered
June 2015 — 11 yrs on file
Profile last updated
June 2, 2021
Year of graduation
2015 — 11 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Kansas #04-43261

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1740660604. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
81,426
Distinct HCPCS
10
Medicare allowed
$1,209,918
HCPCS Description Services Patients Avg allowed
J3262 Injection, tocilizumab, 1 mg 34,520 27 $6
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 20,000 29 $5
J1602 Injection, golimumab, 1 mg, for intravenous use 10,780 32 $13
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 5,800 31 $42
J1745 Injection, infliximab, excludes biosimilar, 10 mg 4,005 33 $33
J9312 Injection, rituximab, 10 mg 2,600 11 $79
J0897 Injection, denosumab, 1 mg 2,160 28 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 503 257 $119
96413 Administration of chemotherapy into vein, 1 hour or less 296 131 $120
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 209 26 $1

In context: peer comparison

Among 2 peers in this city , average services per provider: 6,189. This provider delivers 13× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$814
Transactions
35
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen Inc. 6 $174.56
ABBVIE INC. 5 $121.59
PFIZER INC. 4 $74.88
Novartis Pharmaceuticals Corporation 3 $65.09
Janssen Biotech, Inc. 3 $64.60
UCB, Inc. 3 $58.79
AstraZeneca Pharmaceuticals LP 2 $46.33
Mallinckrodt Hospital Products Inc. 2 $40.03
SOBI, INC 1 $35.81
Alexion Pharmaceuticals, Inc. 1 $25.57
GlaxoSmithKline, LLC. 1 $22.73
GENZYME CORPORATION 1 $18.60
Fresenius Kabi USA, LLC 1 $18.51
Teva Pharmaceuticals USA, Inc. 1 $18.19
HOSPIRA, INC. 1 $14.79

By nature of payment

Food and Beverage
$814

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
399
Patients
102
Total drug cost
$17,023
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 114 37 $9,811
Prednisone Generic 67 30 $752
Methotrexate (Methotrexate Sodium) Brand 52 20 $2,528
Tramadol Hcl Generic 28 0 $218
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 24 0 $298
Sulfasalazine Generic 23 0 $777
Methylprednisolone Generic 20 15 $417
Allopurinol Generic 14 0 $222
Alendronate Sodium Generic 12 0 $51
Folic Acid Generic 12 0 $19

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Jonathan Amos's medical specialty?
Dr. Jonathan Amos practices Rheumatology Physician in Overland Park, KS.
Where does Dr. Jonathan Amos practice?
Dr. Jonathan Amos practices at 5701 W 119Th St Ste 209, Overland Park, KS 662093749. Office phone: 9136619980.
What is Dr. Jonathan Amos's NPI?
Dr. Jonathan Amos's National Provider Identifier (NPI) is 1740660604, issued by NPPES.
Does Dr. Jonathan Amos accept Medicare assignment?
Yes. Dr. Jonathan Amos accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jonathan Amos commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.